Bokf, Na Ionis Pharmaceuticals Inc Transaction History

Bokf, Na

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$42.03 - $53.55 $294 - $374	7 New	7 $0
Q3 2023 Nov 14, 2023	SELL	$38.5 - $47.13 $1.22 Million - $1.5 Million	-31,776 Reduced 54.09%	26,974 $1.22 Million
Q2 2023 Aug 21, 2023	SELL	$34.73 - $43.33 $52,477 - $65,471	-1,511 Reduced 2.51%	58,750 $2.41 Million
Q1 2023 May 11, 2023	BUY	$33.58 - $41.2 $2.02 Million - $2.48 Million	60,261 New	60,261 $2.15 Million
Q3 2021 Nov 10, 2021	SELL	$33.54 - $40.55 $392,753 - $474,840	-11,710 Closed	0 $0
Q1 2021 Apr 21, 2021	BUY	$42.51 - $63.78 $171,102 - $256,714	4,025 Added 52.37%	11,710 $526,000
Q4 2020 Feb 12, 2021	SELL	$45.3 - $60.27 $204,801 - $272,480	-4,521 Reduced 37.04%	7,685 $435,000
Q3 2020 Oct 30, 2020	SELL	$47.45 - $62.95 $86,026 - $114,128	-1,813 Reduced 12.93%	12,206 $579,000
Q2 2020 Aug 12, 2020	SELL	$46.85 - $61.05 $266,998 - $347,923	-5,699 Reduced 28.9%	14,019 $827,000
Q1 2020 May 13, 2020	SELL	$41.6 - $63.4 $115,689 - $176,315	-2,781 Reduced 12.36%	19,718 $932,000
Q4 2019 Feb 12, 2020	SELL	$53.85 - $65.27 $154,226 - $186,933	-2,864 Reduced 11.29%	22,499 $1.36 Million
Q3 2019 Nov 13, 2019	BUY	$59.06 - $72.15 $1.5 Million - $1.83 Million	25,363 New	25,363 $1.52 Million

408

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.73B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Bokf, Na, based on Form 13F filings with the SEC.

Stay updated on Bokf, Na with notifications on news.